Among SSTR antagonists, studies have indicated that 68Ga-NODAGA chelates, for example, 68Ga-NODAGA-LM3, achieve higher tumor uptake and greater uptake in SSTR2-positive organs compared to 68Ga-DOTA-LM3 27. Here, SSTR2 is linked to neoplasm.